GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GI Innovation Inc (XKRX:358570) » Definitions » Stock Based Compensation

GI Innovation (XKRX:358570) Stock Based Compensation : ₩3,154.6 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is GI Innovation Stock Based Compensation?

GI Innovation's Stock Based Compensation for the three months ended in Mar. 2025 was ₩0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was ₩3,154.6 Mil.


GI Innovation Stock Based Compensation Historical Data

The historical data trend for GI Innovation's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GI Innovation Stock Based Compensation Chart

GI Innovation Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial 2,027.07 3,772.31 4,487.72 6,547.19 3,154.59

GI Innovation Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 852.49 683.52 695.79 922.79 -

GI Innovation Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,154.6 Mil.


GI Innovation Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of GI Innovation's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


GI Innovation Business Description

Traded in Other Exchanges
N/A
Address
Songpa-daero 167, Room 1116 of A-dong, Songpa-gu, Seoul, KOR, 05855
GI Innovation Inc is a bio-venture company that researches and develops protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART platform.

GI Innovation Headlines

No Headlines